223 related articles for article (PubMed ID: 32571344)
21. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.
Longjohn MN; Squires WRB; Christian SL
Gene; 2022 May; 821():146211. PubMed ID: 35134470
[TBL] [Abstract][Full Text] [Related]
23. microRNA-181a enhances cell proliferation in acute lymphoblastic leukemia by targeting EGR1.
Verduci L; Azzalin G; Gioiosa S; Carissimi C; Laudadio I; Fulci V; Macino G
Leuk Res; 2015 Apr; 39(4):479-85. PubMed ID: 25740602
[TBL] [Abstract][Full Text] [Related]
24. [microRNA expression in childhood acute granulocytic leukemia and its subtypes].
Luo XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang LD
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):831-5. PubMed ID: 22335948
[TBL] [Abstract][Full Text] [Related]
25. Glymphatic system dysfunction in pediatric acute lymphoblastic leukemia without clinically diagnosed central nervous system infiltration: a novel DTI-ALPS method.
Lin LP; Su S; Hou W; Huang L; Zhou Q; Zou M; Qian L; Cui W; Yang Z; Tang Y; Chen Y
Eur Radiol; 2023 May; 33(5):3726-3734. PubMed ID: 36882529
[TBL] [Abstract][Full Text] [Related]
26. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
[TBL] [Abstract][Full Text] [Related]
27. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia.
Jaime-Pérez JC; Borrego-López MF; Jiménez-Castillo RA; Méndez-Ramírez N; Salazar-Riojas R; Fernández LT; Gómez-Almaguer D
Int J Lab Hematol; 2018 Apr; 40(2):169-174. PubMed ID: 29115725
[TBL] [Abstract][Full Text] [Related]
28. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid.
Ranta S; Nilsson F; Harila-Saari A; Saft L; Tani E; Söderhäll S; Porwit A; Hultdin M; Noren-Nyström U; Heyman M
Pediatr Blood Cancer; 2015 Jun; 62(6):951-6. PubMed ID: 25545289
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
30. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
[TBL] [Abstract][Full Text] [Related]
31. Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation.
Constanso-Conde I; Hermida-Prieto M; Barge-Caballero E; Núñez L; Pombo-Otero J; Suárez-Fuentetaja N; Paniagua-Martín MJ; Barge-Caballero G; Couto-Mallón D; Pan-Lizcano R; Vázquez-Rodríguez JM; Crespo-Leiro MG
J Heart Lung Transplant; 2020 Oct; 39(10):1100-1108. PubMed ID: 32654912
[TBL] [Abstract][Full Text] [Related]
32. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T
Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137
[TBL] [Abstract][Full Text] [Related]
33. Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia.
Durmaz B; Bagca BG; Cogulu O; Susluer SY; Alpay A; Aksoylar S; Gunduz C
Biomed Res Int; 2021; 2021():3207328. PubMed ID: 34877353
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
[TBL] [Abstract][Full Text] [Related]
35. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
[TBL] [Abstract][Full Text] [Related]
37. The expense of sending cerebrospinal fluid for analysis on all lumbar punctures in pediatric acute lymphoblastic leukemia patients.
Wilson J; Liebman MF; Johnston DL
Pediatr Blood Cancer; 2022 Aug; 69(8):e29585. PubMed ID: 35147285
[TBL] [Abstract][Full Text] [Related]
38. Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia.
Jiang Q; Lu X; Huang P; Gao C; Zhao X; Xing T; Li G; Bao S; Zheng H
Biomed Res Int; 2018; 2018():5724686. PubMed ID: 29967774
[TBL] [Abstract][Full Text] [Related]
39. The relationship between cerebrospinal fluid osteopontin level and central nervous system involvement in childhood acute leukemia.
Incesoy-Özdemir S; Sahin G; Bozkurt C; Oren AC; Balkaya E; Ertem U
Turk J Pediatr; 2013; 55(1):42-9. PubMed ID: 23692831
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia.
Garcia KA; Cherian S; Stevenson PA; Martino CH; Shustov AR; Becker PS; Percival MM; Oehler VG; Halpern AB; Walter RB; Orozco JJ; Keel SB; Estey EH; Cassaday RD
Cancer; 2022 Apr; 128(7):1411-1417. PubMed ID: 34931301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
